Natriumpolystyreensulfonaat Focus (Sodium Polystyrene Sulfonate)

Sodium Polystyrene Sulfonate, the active ingredient in Natriumpolystyreensulfonaat Focus, is an ion‑exchange resin presented as a powder for oral and rectal use. It binds potassium in the gastrointestinal tract and is used to lower elevated serum potassium levels in patients with hyperkalemia. GNH USA supplies Natriumpolystyreensulfonaat Focus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Sodium Polystyrene Sulfonate acts as a potassium‑binding ion‑exchange resin to treat conditions associated with excess potassium. - Hyperkalemia: reduces serum potassium concentrations in acute settings. - Chronic hyperkalemia: helps maintain long‑term potassium balance in patients with renal impairment. - Pre‑dialysis preparation: lowers potassium levels before dialysis sessions.

Sodium Polystyrene Sulfonate may cause gastrointestinal and electrolyte disturbances.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Constipation: reduced bowel movements. - Diarrhea: loose stools. - Abdominal discomfort: cramping or pain. - Taste alteration: metallic or salty taste.

Serious or Rare Side Effects: - Intestinal necrosis: severe bowel tissue damage. - Bowel obstruction: blockage requiring medical attention. - Severe electrolyte imbalance: marked hypokalemia or hypernatremia. - Allergic reactions: rash, itching, or swelling. - Hypovolemia: significant fluid loss. - Metabolic acidosis: abnormal blood pH.

Before initiating therapy, clinicians should evaluate patient-specific risk factors and monitor therapy closely. - Baseline assessment: obtain serum potassium and electrolytes prior to start. - Ongoing monitoring: check potassium and sodium levels regularly during treatment. - Renal impairment: adjust use in patients with reduced kidney function. - Gastrointestinal disorders: use cautiously in patients with bowel disease or recent surgery. - Concomitant sorbitol: avoid sorbitol‑containing laxatives due to necrosis risk. - Store at ambient temperature: keep in original container, protect from moisture.

Sodium Polystyrene Sulfonate can affect the absorption and activity of several drugs.

Major Interactions (Avoid): - Sorbitol‑containing laxatives: increase risk of intestinal necrosis. - ACE inhibitors: additive potassium‑raising effect. - Potassium‑sparing diuretics: may exacerbate hyperkalemia.

Moderate Interactions (Monitor Closely): - Digoxin: serum potassium changes can alter digoxin toxicity. - Insulin therapy: monitor for hypokalemia when insulin is used concurrently.